ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 176507 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 176507; 2) Community: the network communities that were significantly associated with the response to NSC 176507; 3) Molecule: the relationships between components within communities and NSC 176507; 4) MDR: the compounds that were significantly associated with the NSC 176507.

NSC Compound Enrichment Correlation
NSC 621322 Null 0.0414190425892871 0.11154612
NSC 622341 Null 0.0414190425892871 0.71305508
NSC 624474 Null 0.0414190425892871 -0.27449724
NSC 625505 Null 0.0414190425892871 0.36845784
NSC 627168 2-[(3-N',N'-Dimethylamino)propyl]-9-methoxy-5-nitro-[6H]- pyrazolo[3,4,5-kl]acridine, free base 0.0414190425892871 0.23527058
NSC 632882 Dicarbonyl[1-(4-cyanaphenyl-NC-azomethyine)- naphthaline-2-olato(O1,N1)]iridium(I) 0.0414190425892871 0.63590495
NSC 634036 4-amino-3-bromo-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d] pyridazin-7-one 0.0414190425892871 0.50470225
NSC 639174 Camptothecin Derivative 0.0414190425892871 0.1299604
NSC 639186 Raltitrexed 0.0414190425892871 0.13194781
NSC 645384 Null 0.0414190425892871 0.57948494
Total:87  Current:68    [First] [Prev] [Next] [Last]